RSU vesting and tax sell-to-cover by KalVista (KALV) Chief Commercial Officer
Rhea-AI Filing Summary
KalVista Pharmaceuticals Chief Commercial Officer Nicole Sweeny reported RSU vesting and related share movements. She acquired 6,250 and 5,000 shares of common stock on derivative exercises of restricted stock units at a price of $0.0000 per share. Each RSU represents a right to receive one share of common stock, with 1/16th of the award vesting on each quarterly anniversary of the vesting commencement date, subject to continued service.
On a separate transaction, she sold 3,975 shares of common stock in an open-market sale at a weighted average price of $15.5668 per share, in multiple trades between $15.5101 and $15.566982. The filing states this sale was a "sell to cover" to satisfy tax withholding obligations arising from RSU vesting and was not a discretionary transaction. Following these transactions, she directly held 47,003 shares of KalVista common stock.
Positive
- None.
Negative
- None.
Insights
Routine RSU vesting with tax sell-to-cover, thesis-neutral.
These transactions reflect standard equity compensation mechanics. Nicole Sweeny exercised restricted stock units for 6,250 and 5,000 shares of KalVista common stock at $0.0000 per share, consistent with RSUs settling into stock rather than cash.
The filing notes that 1/16th of each RSU grant vests on quarterly anniversaries of the vesting commencement date, contingent on continued service. This creates a staggered delivery of shares over time, aligning management incentives with ongoing employment and company performance under the stated schedule.
The 3,975-share sale at a weighted average price of $15.5668, within a range of $15.5101 to $15.566982, is explicitly described as a tax “sell to cover” tied to RSU vesting rather than a discretionary sale. This limits its interpretive significance for investors; subsequent company filings may provide further context on overall insider ownership trends.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,975 | $15.5668 | $62K |
| Exercise | Restricted Stock Unit | 5,000 | $0.00 | -- |
| Exercise | Common Stock | 5,000 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 6,250 | $0.00 | -- |
| Exercise | Common Stock | 6,250 | $0.00 | -- |
Footnotes (1)
- Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.5101 to $15.566982 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through each vesting date.
